Type 2 Diabetes Mellitus Is Independently Associated With Decreased Neural Baroreflex Sensitivity : The Paris Prospective Study III
OBJECTIVE: Impaired baroreflex function is an early indicator of cardiovascular autonomic imbalance. Patients with type 2 diabetes mellitus (T2D) have decreased baroreflex sensitivity (BRS), however, whether the neural BRS (nBRS) and mechanical component of the BRS is altered in those with high metabolic risk (HMR, impaired fasting glucose and metabolic syndrome) or with overt T2D, is unknown. We examined this in a community-based observational study, the Paris Prospective Study III (PPS3). Approach and Results: In 7626 adults aged 50 to 75 years, resting nBRS (estimated by low-frequency gain, from carotid distension rate and RR [time elapsed between two successive R waves] intervals) and mechanical BRS were measured by high-precision carotid echotracking. The associations between overt T2D or HMR as compared with subjects with normal glucose metabolism and nBRS or mechanical BRS were quantified using multivariable linear regression analysis. There were 319 subjects with T2D (61±6 years, 77% male), 1450 subjects with HMR (60±6 years, 72% male), and 5857 subjects with normal glucose metabolism (59±6 years, 57% male). Compared with normal glucose metabolism, nBRS was significantly lower in HMR subjects (β=-0.07 [95% CI, -0.12 to -0.01]; P=0.029) and in subjects with T2D (β=-0.18 [95% CI, -0.29 to -0.07]; P=0.002) after adjustment for confounding and mediating factors. Subgroup analysis suggests significant and independent alteration in mechanical BRS only among HMR patients who had both impaired fasting glucose and metabolic syndrome.
CONCLUSIONS: In this community-based study of individuals aged 50 to 75, a graded decrease in nBRS was observed in HMR subjects and patients with overt T2D as compared with normal glucose metabolism subjects.
| Errataetall: |
ErratumIn: Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):e184. - PMID 32459542 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Arteriosclerosis, thrombosis, and vascular biology - 40(2020), 5 vom: 19. Mai, Seite 1420-1428 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cseh, Domonkos [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Baroreflex |
|---|
| Anmerkungen: |
Date Completed 14.07.2020 Date Revised 14.07.2020 published: Print-Electronic ErratumIn: Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):e184. - PMID 32459542 Citation Status MEDLINE |
|---|
| doi: |
10.1161/ATVBAHA.120.314102 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307747433 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307747433 | ||
| 003 | DE-627 | ||
| 005 | 20231225130235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/ATVBAHA.120.314102 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1025.xml |
| 035 | |a (DE-627)NLM307747433 | ||
| 035 | |a (NLM)32188272 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cseh, Domonkos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Type 2 Diabetes Mellitus Is Independently Associated With Decreased Neural Baroreflex Sensitivity |b The Paris Prospective Study III |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.07.2020 | ||
| 500 | |a Date Revised 14.07.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):e184. - PMID 32459542 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVE: Impaired baroreflex function is an early indicator of cardiovascular autonomic imbalance. Patients with type 2 diabetes mellitus (T2D) have decreased baroreflex sensitivity (BRS), however, whether the neural BRS (nBRS) and mechanical component of the BRS is altered in those with high metabolic risk (HMR, impaired fasting glucose and metabolic syndrome) or with overt T2D, is unknown. We examined this in a community-based observational study, the Paris Prospective Study III (PPS3). Approach and Results: In 7626 adults aged 50 to 75 years, resting nBRS (estimated by low-frequency gain, from carotid distension rate and RR [time elapsed between two successive R waves] intervals) and mechanical BRS were measured by high-precision carotid echotracking. The associations between overt T2D or HMR as compared with subjects with normal glucose metabolism and nBRS or mechanical BRS were quantified using multivariable linear regression analysis. There were 319 subjects with T2D (61±6 years, 77% male), 1450 subjects with HMR (60±6 years, 72% male), and 5857 subjects with normal glucose metabolism (59±6 years, 57% male). Compared with normal glucose metabolism, nBRS was significantly lower in HMR subjects (β=-0.07 [95% CI, -0.12 to -0.01]; P=0.029) and in subjects with T2D (β=-0.18 [95% CI, -0.29 to -0.07]; P=0.002) after adjustment for confounding and mediating factors. Subgroup analysis suggests significant and independent alteration in mechanical BRS only among HMR patients who had both impaired fasting glucose and metabolic syndrome | ||
| 520 | |a CONCLUSIONS: In this community-based study of individuals aged 50 to 75, a graded decrease in nBRS was observed in HMR subjects and patients with overt T2D as compared with normal glucose metabolism subjects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a baroreflex | |
| 650 | 4 | |a blood pressure | |
| 650 | 4 | |a carotid sinus | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a metabolic syndrome | |
| 650 | 4 | |a vascular stiffness | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Climie, Rachel E |e verfasserin |4 aut | |
| 700 | 1 | |a Offredo, Lucile |e verfasserin |4 aut | |
| 700 | 1 | |a Guibout, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Frédérique |e verfasserin |4 aut | |
| 700 | 1 | |a Zanoli, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Danchin, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Sharman, James E |e verfasserin |4 aut | |
| 700 | 1 | |a Laurent, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Jouven, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Boutouyrie, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Empana, Jean-Philippe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arteriosclerosis, thrombosis, and vascular biology |d 1995 |g 40(2020), 5 vom: 19. Mai, Seite 1420-1428 |w (DE-627)NLM074658522 |x 1524-4636 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2020 |g number:5 |g day:19 |g month:05 |g pages:1420-1428 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/ATVBAHA.120.314102 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2020 |e 5 |b 19 |c 05 |h 1420-1428 | ||